Laurus Labs Limited

₹2,340As of Sun 8 Nov 2026, 12:00 UTC
NSE:LAURUSLABSHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 38.78%
Div yield 0.10%
ROE 23.97%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.22
PE TTM 94.44
TSR TTM 145.72%
Mkt cap ₹1.264T
ROIC 17.21%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹2,542
8.64%
(97.62%)
Hold 2|4|9|2|3
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
31.67
31.31
33.15
31.49
29.72%
21.18%
16.24%
10.51%
Revenue₹B
66.92
70.25
72.76
74.38
6.70%
9.44%
15.77%
16.38%
Peers (US$13.46B)
Cap (US$)
PE
12.72B
28.64x
12.14B
39.36x
Capital
TTM
5Y
10Y
Leveragex
0.766
0.213
0.193
EBIT/Intx
0.046
0.072
0.076
Own earn%
(446.35)
(9.09)
(10.52)
Sh yield%
41.62
67.92
66.83
Owners
Insiders/Inst%
12.17
80.73
Short interest%
5.41
SBC / revenue%
0.60
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
4–11
$1 testx
0.6
Incr. ROIC%
27